US2017175093A1PendingUtilityA1
Thermus brockianus nucleic acid polymerases
Est. expiryNov 30, 2021(expired)· nominal 20-yr term from priority
C12Y 207/07007C12P 19/34Y02P20/52C12Q 1/6869C12N 9/1241C12N 9/1252
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides nucleic acids and polypeptides for nucleic acid polymerases from a thermophilic organism, Thermus brockianus . The invention also provides methods for using these nucleic acids and polypeptides.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated nucleic acid encoding a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-16.
2 . An isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10 having a mutation that decreases 5-3′ exonuclease activity.
3 . The isolated nucleic acid of claim 2 , wherein the derivative nucleic acid polymerase has decreased 5-3′ exonuclease activity relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
4 . An isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO: 9-10 having a mutation that reduces discrimination against dideoxynucleotide triphosphates.
5 . The isolated nucleic acid of claim 4 , wherein the derivative nucleic acid polymerase has reduced discrimination against dideoxynucleotide triphosphates relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
6 . An isolated nucleic acid encoding a nucleic polymerase comprising any one of SEQ ID NO:1-8.
7 . An isolated nucleic acid comprising a nucleotide sequence complementary to any one of SEQ ID NO:1-8.
8 . An isolated nucleic acid encoding a nucleic acid polymerase from Thermus brockianus comprising amino acid sequence with at least 96% identity to any one of SEQ ID NO:9-16.
9 . A vector comprising an isolated nucleic acid encoding a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-16.
10 . A vector comprising an isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10 having a mutation that decreases 5-3′ exonuclease activity.
11 . The vector of claim 10 , wherein the derivative nucleic acid polymerase has decreased 5-3′ exonuclease activity relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
12 . A vector comprising an isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO: 9-10 having a mutation that reduces discrimination against dideoxynucleotide triphosphates.
13 . The vector of claim 12 , wherein the derivative nucleic acid polymerase has reduced discrimination against dideoxynucleotide triphosphates relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
14 . A vector comprising an isolated nucleic acid encoding a nucleic polymerase comprising any one of SEQ ID NO:1-8.
15 . A vector comprising an isolated nucleic acid comprising a nucleotide sequence complementary to any one of SEQ ID NO:1-8.
16 . A vector comprising an isolated nucleic acid encoding a nucleic acid polymerase from Thermus brockianus comprising amino acid sequence with at least 96% identity to any one of SEQ ID NO:9-16.
17 . An expression vector comprising a promoter operably linked to an isolated nucleic acid encoding a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-16.
18 . An expression vector comprising a promoter operably linked to an isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10 having a mutation that decreases 5-3′ exonuclease activity.
19 . The expression vector of claim 18 , wherein the derivative nucleic acid polymerase has decreased 5-3′ exonuclease activity relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
20 . An expression vector comprising a promoter operably linked to an isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO: 9-10 having a mutation that reduces discrimination against dideoxynucleotide triphosphates.
21 . The expression vector of claim 20 , wherein the derivative nucleic acid polymerase has reduced discrimination against dideoxynucleotide triphosphates relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
22 . An expression vector comprising a promoter operably linked to an isolated nucleic acid encoding a nucleic polymerase comprising any one of SEQ ID NO:1-8.
23 . An expression vector comprising a promoter operably linked to an isolated nucleic acid comprising a nucleotide sequence complementary to any one of SEQ ID NO:1-8.
24 . An expression vector comprising a promoter operably linked to an isolated nucleic acid encoding a nucleic acid polymerase from Thermos brockianus comprising amino acid sequence with at least 96% identity to any one of SEQ ID NO:9-16.
25 . A host cell comprising an isolated nucleic acid encoding a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-16.
26 . A host cell comprising an isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10 having a mutation that decreases 5-3′ exonuclease activity.
27 . The host cell of claim 26 , wherein the derivative nucleic acid polymerase has decreased 5-3′ exonuclease activity relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
28 . A host cell comprising an isolated nucleic acid encoding a derivative nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO: 9-10 having a mutation that reduces discrimination against dideoxynucleotide triphosphates.
29 . The host cell of claim 28 , wherein the derivative nucleic acid polymerase has reduced discrimination against dideoxynucleotide triphosphates relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
30 . A host cell comprising an isolated nucleic acid encoding a nucleic polymerase comprising any one of SEQ ID NO:1-8.
31 . A host cell comprising an isolated nucleic acid encoding a nucleic acid polymerase from Thermus brockianus comprising amino acid sequence with at least 96% identity to any one of SEQ ID NO:9-16.
32 . An isolated nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-16.
33 . An isolated nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-49.
34 . An isolated nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10 having a mutation that decreases 5-3′ exonuclease activity.
35 . The isolated nucleic acid polymerase of claim 34 , wherein the derivative nucleic acid polymerase has decreased 5-3′ exonuclease activity relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
36 . An isolated nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10 having a mutation that reduces discrimination against dideoxynucleotide triphosphates.
37 . The isolated nucleic acid polymerase of claim 36 , wherein the derivative nucleic acid polymerase has reduced discrimination against dideoxynucleotide triphosphates relative to a nucleic acid polymerase comprising any one of amino acid sequences SEQ ID NO:9-10.
38 . A kit comprising a container containing a nucleic acid polymerase, wherein the nucleic acid polymerase comprises any one of amino acid sequences SEQ ID NO:9-49.
39 . A kit comprising a container containing a nucleic acid polymerase, wherein the nucleic acid polymerase comprises any one of amino acid sequences SEQ ID NO:9-16.
40 . The kit of claim 38 or 39 further comprising a container containing an unlabeled nucleotide, a labeled nucleotide, a balanced mixture of nucleotides, a chain terminating nucleotide, a nucleotide analog, a buffer solution, a solution containing magnesium, a cloning vector, a restriction endonuclease, a sequencing primer, a solution containing reverse transcriptase, or a DNA or RNA amplification primer.
41 . The kit of claim 38 or 39 , adapted for performing DNA sequencing, DNA amplification, reverse transcription, RNA amplification or primer extension.
42 . A method of making a nucleic acid polymerase comprising any one of SEQ ID NO:9-16 that comprises, incubating under conditions sufficient for RNA transcription and translation a host cell comprising a nucleic acid encoding a polypeptide comprising any one of SEQ ID NO:9-16 operably linked to a promoter.
43 . The method of claim 42 wherein the nucleic acid comprises any one SEQ ID NO:1-8.
44 . A nucleic acid polymerase made by the method of claim 42 .
45 . A method of synthesizing DNA comprising contacting a polypeptide comprising any one of SEQ ID NO:9-16 with a DNA under conditions sufficient to permit polymerization of DNA.
46 . A method of synthesizing DNA comprising contacting a polypeptide comprising any one of SEQ ID NO:9-49 with a DNA under conditions sufficient to permit polymerization of DNA.
47 . A method for thermocyclic amplification of nucleic acid comprising:
(a) contacting a nucleic acid with a thermostable polypeptide having any one of SEQ ID NO:9-49 under conditions suitable for amplification of said nucleic acid; and (b) amplifying the nucleic acid.
48 . The method of claim 47 that further comprises cycling the temperature to denature nucleic acids, to renature a primer onto a template nucleic acid and to polymerize a nucleic acid strand complementary to the template nucleic acid.
49 . The method of claim 47 wherein the thermocyclic amplification of DNA is performed by Strand Displacement Amplification.
50 . The method of claim 47 wherein thermocyclic amplification of DNA is performed by Polymerase Chain Reaction.
51 . A method of primer extension comprising contacting a polypeptide comprising any one of SEQ ID NO:9-16 with a primer and a nucleic acid that is complementary to the primer under conditions sufficient to permit polymerization of DNA.
52 . The method of claim 51 wherein the nucleic acid is DNA.
53 . The method of claim 51 wherein the primer extension is done to sequence the nucleic acid.
54 . The method of claim 51 wherein the primer extension is done to amplify the nucleic acid.Join the waitlist — get patent alerts
Track US2017175093A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.